
155.64 Delayed Data As of Jan 27 | ![]() Today’s Change | 125.36 Today|||52-Week Range 169.98 | -2.30% Year-to-Date |
Nepsis Inc. Buys 2, Sells 3 in 4th Quarter Jan 25 / GuruFocus News - Paid Partner Content | 2 Promising New Growth Stocks to Watch in 2023 Jan 23 / MotleyFool.com - Paid Partner Content |
Strength Seen in Catalyst (CPRX): Can Its 9.2% Jump Turn into More Strength? Jan 25 / Zacks.com - Paid Partner Content | Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival Jan 20 / Zacks.com - Paid Partner Content |
Previous close | 155.55 |
Today’s open | 155.20 |
Day’s range | 153.63 - 156.76 |
Volume | 15,368 |
Average volume (3 months) | 550,646 |
Market cap | $9.9B |
Earnings growth (last year) | -228.94% |
Earnings growth (this year) | +9.01% |
Earnings growth (next 5 years) | +7.04% |
Revenue growth (last year) | +30.91% |
P/E ratio | NM |
Price/Sales | 2.46 |
Price/Book | 2.44 |
Today’s change | Today’s % change | |
---|---|---|
CTLTCatalent Inc | +1.38 | +2.64% |
RDYDr Reddy's Laborator... | 0.00 | 0.00% |
SRPTSarepta Therapeutics... | -0.02 | -0.02% |
RGENRepligen Corp | 0.00 | 0.00% |
Next reporting date | February 28, 2023 |
EPS forecast (this quarter) | $4.47 |
Annual revenue (last year) | $3.1B |
Annual profit (last year) | -$329.7M |
Net profit margin | -10.65% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |